Nicole H Lazarus

Title: **Innovations of Nicole H Lazarus: A Pioneer in Immunocytostaining Methods**

Introduction

Nicole H Lazarus, located in Sonoma, California, is an accomplished inventor known for her significant contributions to the field of immunocytostaining. With a singular patent to her name, Lazarus has developed a groundbreaking method that enhances the detection of rare events in cellular samples. Her innovative approach has transformative potential in various scientific and medical applications.

Latest Patents

Nicole's notable patent is titled "Immunocytostaining methods for enhanced dye ratio discrimination in rare event detection." This patent details a method for preparing samples that contain cells of interest, utilizing a laser-based system for excitation and emission collection. The technique allows for direct and ratio-based measurements of fluorescent signals, improving the discrimination between false positives and true positives in imaging events. By employing a laser spot with varying diameters, the method effectively reduces errors in rare event detection and enhances the reliability of imaging systems.

Career Highlights

Currently, Nicole is associated with the Palo Alto Research Center Inc., where her innovative work continues to inspire advancements in research. Her expertise and dedication to her field have made her a valued contributor to the scientific community.

Collaborations

Throughout her career, Nicole has collaborated closely with colleagues such as Huangpin Ben Hsieh and Robert Thomas Krivacic. These collaborations not only highlight her ability to work effectively within a team but also underscore the importance of cross-disciplinary efforts in driving innovation.

Conclusion

Nicole H Lazarus exemplifies the spirit of innovation through her advancements in immunocytostaining methods. Her patented technology represents a significant leap forward in the detection of rare cellular events, showcasing her expertise and commitment to enhancing scientific research. As she continues her work at the Palo Alto Research Center Inc., the impact of her innovations is sure to resonate within both academic and medical communities.